Home » BLOG » This healthtech start-up that delivers more accurate drug doses has raised a $2.6m Series A round at a $20m valuation

This healthtech start-up that delivers more accurate drug doses has raised a $2.6m Series A round at a $20m valuation

DoseMe raises $2.6 million Series A funding round

DoseMe, a privately held digital medical solutions provider, recently announced it had closed a $2.6 million Series A financing round, valuing the company at $20 million. The funding was secured from two veteran healthcare executives, Greg Spurgin and Gary Cunningham, both founders of leading US outpatient orthopaedic physical therapy company Results Physiotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *